Presentation Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation Presenter: C.W. Lee October 10, 2013
Presentation Clinical Outcomes of PCI Performed Without Preprocedural Aspirin Presenter: M. Kenaan October 02, 2013
Presentation ESC 2013 Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry Presenter: 32040|Roxana Mehran September 01, 2013
Presentation Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications Presenter: Y. Naruse August 26, 2013
Presentation The Effects of Apixaban on Hospitalizations in Patients With Different Types of Atrial Fibrillation Presenter: Stefan H. Hohnloser August 01, 2013
Presentation Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of DES Presenter: Gregg W. Stone July 30, 2013
Presentation Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients Presenter: B. A. Steinberg July 24, 2013
Presentation Clopidogrel with Aspirin in Acute Minor Stroke or TIA Presenter: Yongjun Wang June 26, 2013
Presentation EuroPCR 2013 The Unplanned DAPT Discontinuation Patient: How Can I Make Informed Decisions? Presenter: Sigmund Silber May 22, 2013
Presentation Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES Presenter: K. Tandjung April 26, 2013
Presentation TCTAP 2013 The Future Is: New Antiplatelet Agents, Selective Platelet Function Testing, and Patient-Specific DAPT Duration Presenter: Matthew J. Price April 24, 2013
Presentation TCTAP 2013 Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive Presenter: Adnan Kastrati April 24, 2013
Presentation Decision Dilemmas in Adjunctive Pharmacology Choices in PCI Patients Presenter: Roxana Mehran April 15, 2013
Presentation Nuisance Bleeding with Prolonged Dual Antiplatelet Therapy After AMI and Its Impact on Health Status Presenter: A. P. Amin March 26, 2013
Presentation ADAPT-DES One-Year Results: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes Presenter: Gregg W. Stone March 26, 2013
Presentation PCI Outcomes 2013 DAPT + Oral Anticoagulation: Indications and Risk Amelioration Presenter: C. Michael Gibson March 07, 2013
Presentation TCT 2013 Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. Presenter: Salvatore Cassese, Robert Byrne, Tomohisa Tada, Lamin King, Adnan Kastrati January 31, 2013
Presentation TCT 2013 Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability But Is Associated with Clinical Outcome After Percutaneous Coronary Intervention Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuck Kang, Jung-Kyu Han, Sang Eun Lee, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim January 31, 2013
Presentation TCT 2013 Can Amelioration of HDL-C Level by Pitavastatin Improve Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention? Presenter: Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Amro Elnagar, Sung Il Im, Sun Won Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong January 31, 2013
Presentation Should Duration of Dual Antiplatelet Therapy Depend on the Type and/or Potency of Implanted Stent? Presenter: Marco Valgimigli January 16, 2013